Command Palette

Search for a command to run...

Clinical Trials · NCT01524705

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

CompletedPhase 4Exenatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Washington
Enrollment
102
Start date
Aug 2012
Locations
12 sites, United States
Primary endpoint
Coefficient of Variation at 26 Weeks Minus Coefficient of Variation at Baseline
View Exenatide compound reference